USA Rare Earth Stock Is Down 60% -- Is September the Month to Buy the Dip?

USA Rare Earth shares traded at $17.66, roughly 54% below their $43.98 October 2025 peak, despite the company’s acquisition of Brazil-based Serra Verde for $2.8 billion, largely funded with newly issued stock. The company has not yet generated revenue, but Serra Verde is described as the Western Hemisphere’s only scaled producer of key rare-earth minerals used in defense, technology and alternative-energy applications. U.S. government investment and financing/purchasing support improve its strategic position as the U.S. seeks to reduce reliance on Chinese mineral supply, though the stock remains highly speculative and suited only to risk-tolerant investors.

Analysis

USAR is no longer a pure development-stage domestic-mining optionality vehicle; its equity now embeds execution on an operating Brazilian asset, integration of a large all-stock acquisition, and eventual U.S. downstream ambitions. The central valuation issue is dilution rather than the share-price drawdown: until pro forma shares outstanding, Serra Verde production/ramp economics, realized pricing, and acquisition financing terms are fully reconciled, a lower nominal stock price provides little evidence of cheapness. The concentrated strategic value of heavy rare earth output could support a scarcity premium, but only if production is reliably qualified into non-Chinese magnet supply chains.

Near-term, the likely catalyst path is technical: closing mechanics, pro forma cap table disclosure, offtake/customer details, and evidence that government support converts into contracted cash flows rather than non-binding strategic endorsement. A successful U.S. procurement or defense-linked offtake could re-rate USAR within 1-3 months because it reduces both price and volume uncertainty; conversely, any equity issuance beyond the announced transaction or a delayed production ramp would pressure the stock disproportionately given its SPAC-era shareholder base and limited fundamental valuation anchors.

The contrarian point is that strategic-minerals enthusiasm can overvalue mine ownership while underestimating separation, qualification, and magnet-making bottlenecks. MP is the cleaner public comparator for U.S. policy optionality, while Lynas (LYC.AX) offers a more mature ex-China operating benchmark; USAR needs to demonstrate that its asset mix earns a premium to these alternatives rather than merely serving as a geopolitical narrative proxy. Do not extrapolate promotional references to unrelated mega-cap winners into a probability-weighted underwriting case.

Key Decisions for Investors

• No immediate core position in USAR; place on catalyst watch through the first complete pro forma quarterly filing. Require disclosed fully diluted share count, Serra Verde unit costs/production guidance, net-debt maturity profile, and binding offtake terms before underwriting fair value.
• For a small high-risk event allocation only, accumulate USAR in tranches after transaction disclosures if the stock holds above $15 and no incremental equity financing is indicated; target a 3-6 month strategic-offtake re-rating, with a hard stop on a break below $12 or any guidance indicating ramp delay beyond two quarters.
• Use a relative-value framework rather than a naked strategic-minerals beta trade: long USAR only against a short basket of higher-beta pre-revenue critical-minerals developers, not against MP. USAR's operating-asset exposure should outperform development-only peers if procurement activity accelerates, but it should not be assumed to outperform MP on execution quality.
• Monitor U.S. defense/DOE awards and long-term NdPr/Dy/Tb pricing monthly. A binding government-backed purchase agreement is the upside trigger; declining rare-earth pricing, weak Serra Verde recoveries, or additional dilution falsifies the thesis.